Duchenne in 2013 DUCHENNE IN Cape Town, February 2013

Size: px
Start display at page:

Download "Duchenne in 2013 DUCHENNE IN Cape Town, February 2013"

Transcription

1 Duchenne in 2013 DUCHENNE IN 2013 Cape Town, February 2013 Doug Biggar MD Muscular Dystrophy Foundation Holland Bloorview Doug Kids Biggar Rehabilitation Hospital Capetown, February2013

2 Objectives for today Impact of corticosteroids on natural history Hurdles for new therapies New strategies for treatment Therapeutic dose of HOPE

3 Today Boys Become Adults With Adult Needs

4 Steroids the Good: So most agree that: Corticosteroids help muscle strength They slow the progression of muscle weakness Best to start when boys are walking Best to give once a day, every day if you can Balanced discussion of benefits and risks More studies are needed

5 What is Good? Short-term Most boys, but not all, have more energy Long-term Walking Breathing Heart Spine Arm strength

6 Preserved Muscle Function

7 Walking No corticosteroids stop around 10 years old With corticosteroids walk 3-5 years longer

8 Better Pulmonary Function

9 FVC Percent Predicted PULMONARY FUNCTION Untreated Treated Age in years

10 Pulmonary Function At 18 years, boys on steroids should have: Fewer lung infections A better cough Fewer admissions to hospital for pneumonia Very few need night time ventilation

11 Preserved Cardiac Function

12 Cardiac Function yr. - prospective Control n=26 Deflazacort n=67 P Age NS LVEF (<45%) 70 % 5% <0.001

13 Delayed Scoliosis

14 Scoliosis Surgery No steroids 90% boys done around 15 years Need help feeding after surgery Steroid treated: Only 10%, not 90%, of boys done at years Can self feed after surgery

15 Steroids: the Bad Variable and can include: Shorter height Reduced bone health Weight gain Delayed puberty And more

16 You will be short

17 But that could be good, no?

18 What about bones?

19 What makes bones healthy? Genetics 70-80% Physical activity Other things: calcium, vitamin D etc

20 What about my son s bones? Even young boys have reduced bone density Worse with less walking ~35% break a long bone (leg or arm), with or without steroids Vertebral (back bone) fractures only occur on steroids

21 Soooo..How bad? Probably not worse with deflazacort Risk of fractures: long bones vertebrae Can be treated, if needed More research needed

22 And puberty? It will be delayed. It will happen. But while you are waiting. you will look younger than you are no facial hair high voice BUT no pimples no need to shave

23 And Weight gain, can be bad Some boys are thin, no problem. Some boys gain a lot of weight, even not on steroids- big problem. Most boys: big appetite less active want treats like all boys a real challenge for most families

24 What is the bottom line?

25 This is one bottom line?

26 The bottom line:. The good must be better than the bad Major benefits include improved: Skeletal muscles Pulmonary Cardiac Scoliosis Arm strength

27 Living with Duchenne Can be difficult but many of the issues are not medical but rather psychosocial. I worry less about premature death than my social isolation, adult friends, job. My aspirations are like yours: good job, friends, a partner and family.

28

29 Therapeutic Strategies Gene transfer Cell therapies Up regulation of alternative proteins Increase muscle bulk Focus on downstream pathology Modify the mutation: exon skipping, stop codon suppression

30 Hurdles for Treatments Animal models Biomarkers Delivery Host immune response Clinical variability Outcome measures

31 Therapeutic Dose of HOPE New understanding Better science and resources Partnerships: parents, science & industry Patient registries Regulators understanding Ethics Review Boards

32 LIFE CAN BE A GOOD RIDE

33 THANK YOU THANK YOU!

34 THANK YOU THANK YOU!

35 CARE Guidelines Consensus process Scientific publication Dissemination to: Families Care providers Policy makers Revise & update

36 Using Knowledge to Improve Care The diagnosis and management of Duchenne Muscular Dystrophy: Lancet Jan/Feb 2010

37 Using Knowledge to Improve Care The diagnosis and management of Duchenne Muscular Dystrophy: Lancet Jan/Feb 2010

38 Bottom Line: Common side effects: Short Delayed puberty Vertebral fragility fractures Weight gain

39 What are the Unknowns? Benefits of prednisone over deflazacort? When is the best time to start? What is the best dose to use at different ages? Do steroids help all boys? Do you ever stop steroids? When will there be a drug with only the good effects and not the bad?

Duchenne Muscular Dystrophy:

Duchenne Muscular Dystrophy: Duchenne Muscular Dystrophy: Corticosteroid Treatment PPMD Annual Conference CONNECT Douglas Biggar, Bloorview Kids Rehab, Toronto, Canada. Why Corticosteroids in DMD? Prednisone shown to change the course

More information

What are steroids and how do they work?

What are steroids and how do they work? For over 20 years boys with Duchenne muscular dystrophy (MD) have been treated with steroids, which is currently the only medication proven to slow the progression of the condition. In Australia, more

More information

DMD STANDARDS OF CARE

DMD STANDARDS OF CARE DMD STANDARDS OF CARE PPMD 2019 END DUCHENNE TOUR Russell Butterfield MD, PhD Director, Muscular Dystrophy Clinics Associate Professor University of Utah, School of Medicine February 2, 2019 DISCLOSURES

More information

CARE CONSIDERATIONS FOR DUCHENNE MUSCULAR DYSTROPHY

CARE CONSIDERATIONS FOR DUCHENNE MUSCULAR DYSTROPHY IMPORTANT NEW UPDATE A Summary of the Report of the DMD Care Considerations Working Group Intended for US healthcare professionals only. CARE CONSIDERATIONS FOR DUCHENNE MUSCULAR DYSTROPHY Full article

More information

The Canadian experience with long term deflazacort treatment in Duchenne. muscular dystrophy.

The Canadian experience with long term deflazacort treatment in Duchenne. muscular dystrophy. Acta Myologica 2012; XXXI: p. 16-20 The Canadian experience with long term deflazacort treatment in Duchenne muscular dystrophy Laura C. McAdam 1 2, Amanda L. Mayo 3, Benjamin A. Alman 1 4 5, W. Douglas

More information

SCOTTISH MUSCLE NETWORK DUCHENNE MUSCULAR DYSTROPHY TRANSITION SOME USEFUL THINGS TO KNOW ABOUT HEALTH AROUND ADOLESCENCE

SCOTTISH MUSCLE NETWORK DUCHENNE MUSCULAR DYSTROPHY TRANSITION SOME USEFUL THINGS TO KNOW ABOUT HEALTH AROUND ADOLESCENCE SCOTTISH MUSCLE NETWORK DUCHENNE MUSCULAR DYSTROPHY TRANSITION SOME USEFUL THINGS TO KNOW ABOUT HEALTH AROUND ADOLESCENCE 02 Changes in our lives can be stressful and leaving school and moving into the

More information

DEFLAZACORT Generic Brand HICL GCN Exception/Other DEFLAZACORT EMFLAZA 11668

DEFLAZACORT Generic Brand HICL GCN Exception/Other DEFLAZACORT EMFLAZA 11668 Generic Brand HICL GCN Exception/Other DEFLAZACORT EMFLAZA 11668 GUIDELINES FOR USE INITIAL CRITERIA (NOTE: FOR RENEWAL CRITERIA SEE BELOW) 1. Does the patient have a diagnosis of Duchenne muscular dystrophy

More information

Rehabilitation and psychosocial aspects in DMD care

Rehabilitation and psychosocial aspects in DMD care Rehabilitation and psychosocial aspects in DMD care Budapest, 18-04-2012 Birgit F. Steffensen, Physiotherapist, PhD The National Danish Rehabilitation Centre for Neuromuscular Diseases Denmark Demographics:

More information

Action Duchenne Conference London, 2 nd -4 th November 2007

Action Duchenne Conference London, 2 nd -4 th November 2007 Action Duchenne Conference London, 2 nd -4 th November 2007 In November 2007 I attended the Action Duchenne annual conference in London. It was a very full agenda, with a range of presentations from internationally

More information

Muscular Dystrophy UK s Adult North Star Network. Care recommendations for adults with Duchenne a consultation

Muscular Dystrophy UK s Adult North Star Network. Care recommendations for adults with Duchenne a consultation Muscular Dystrophy UK s Adult North Star Network Care recommendations for adults with Duchenne a consultation Background: The North Star Network was set up in 2003 to help drive improvements in services

More information

HARVARD PILGRIM HEALTH CARE RECOMMENDED MEDICATION REQUEST GUIDELINES

HARVARD PILGRIM HEALTH CARE RECOMMENDED MEDICATION REQUEST GUIDELINES Generic Brand HICL GCN Exception/Other DEFLAZACORT EMFLAZA 11668 If the caller wishes to initiate a request then a MRF must be completed. This drug requires a written request for prior authorization. All

More information

Bringing Differentiated Therapies to Duchenne Patients Stuart Peltz, PhD

Bringing Differentiated Therapies to Duchenne Patients Stuart Peltz, PhD Bringing Differentiated Therapies to Duchenne Patients Stuart Peltz, PhD Jul-18 1 Main Objectives Translarna TM (ataluren) Update FDA pathway forward for NDA Ongoing clinical trials EMFLAZA (deflazacort)

More information

TODAY IS THE DAY I STAND UP TO IPF. fightipf.co.uk

TODAY IS THE DAY I STAND UP TO IPF. fightipf.co.uk fightipf.co.uk SUPPORTING IPF AWARENESS TODAY IS THE DAY I STAND UP TO IPF For people diagnosed with Idiopathic Pulmonary Fibrosis: A guide to help you discuss your condition and management options with

More information

Spinal injury. Structure of the spine

Spinal injury. Structure of the spine Spinal injury Structure of the spine Some understanding of the structure of the spine (spinal column) and the spinal cord is important as it helps your Neurosurgeon explain about the part of the spine

More information

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Proposed Highly Specialised Technology Evaluation

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Proposed Highly Specialised Technology Evaluation NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Proposed Highly Specialised Technology Evaluation Drisapersen for treating Duchenne muscular Draft scope (pre-referral) Draft remit/evaluation objective

More information

Key Concepts Guide. Rev. March 2015 Page 1 of 13

Key Concepts Guide. Rev. March 2015 Page 1 of 13 Key Concepts Guide Key concepts are main ideas. They convey big-picture ideas. Birth control is good at preventing pregnancy and Everyone has the right to say who touches their body and how are both key

More information

IMPROVING THE DIAGNOSIS AND MANAGEMENT OF OSTEOPOROSIS IN CANADA

IMPROVING THE DIAGNOSIS AND MANAGEMENT OF OSTEOPOROSIS IN CANADA COPING A newsletter from COPN October 15, 2010 Remember: You can live well with osteoporosis! If you have received this newsletter from the Canadian Osteoporosis Patient Network (COPN) You are a COPN member

More information

NO BONES ABOUT IT. What you need to know about osteoporosis _cov_a _cov_b _cov_c

NO BONES ABOUT IT. What you need to know about osteoporosis _cov_a _cov_b _cov_c NO BONES ABOUT IT What you need to know about osteoporosis 210054900_cov_a 210054900_cov_b 210054900_cov_c WHAT S IT ALL ABOUT? Your bones have a thick, strong wall on the outside. Inside this wall, the

More information

Subject: Emflaza (deflazacort) Original Effective Date: 7/7/2017. Policy Number: MCP-298 Revision Date(s): 1/12/2018. Review Date(s): DISCLAIMER

Subject: Emflaza (deflazacort) Original Effective Date: 7/7/2017. Policy Number: MCP-298 Revision Date(s): 1/12/2018. Review Date(s): DISCLAIMER Subject: Emflaza (deflazacort) Original Effective Date: 7/7/2017 Policy Number: MCP-298 Revision Date(s): 1/12/2018 Review Date(s): DISCLAIMER This Molina Clinical Policy (MCP) is intended to facilitate

More information

Learning Objectives. ! Students will become familiar with the 3 treatment solutions for osteoporosis. ! Students should be able to define osteoporosis

Learning Objectives. ! Students will become familiar with the 3 treatment solutions for osteoporosis. ! Students should be able to define osteoporosis Learning Objectives! Students should be able to define osteoporosis! Students should be able to identify some risk factors of osteoporosis! Students should be able to identify some of the people in the

More information

GSK Q&A For Patient Advocacy Groups: 04 October 2013 For reactive use in response to enquiries from patient groups only

GSK Q&A For Patient Advocacy Groups: 04 October 2013 For reactive use in response to enquiries from patient groups only 1. Will assessments and visits continue now that the patients are no longer receiving study treatment? Yes, while dosing of boys in the ongoing studies (DMD114349, DMD115501 and DMD114673) has been placed

More information

CENTENE PHARMACY AND THERAPEUTICS DRUG REVIEW 2Q17 April May

CENTENE PHARMACY AND THERAPEUTICS DRUG REVIEW 2Q17 April May BRAND NAME Emflaza GENERIC NAME Deflazacort MANUFACTURER Marathon Pharmaceuticals, LLC DATE OF APPROVAL February 9, 2017 PRODUCT LAUNCH DATE Anticipated availability in early 2017 REVIEW TYPE Review type

More information

Scoliosis. About idiopathic scoliosis and its treatment. Patient and Family Education. What types of scoliosis are there?

Scoliosis. About idiopathic scoliosis and its treatment. Patient and Family Education. What types of scoliosis are there? Patient and Family Education Scoliosis About idiopathic scoliosis and its treatment This handout covers the most common type of scoliosis, adolescent idiopathic scoliosis. Other types of scoliosis may

More information

Southeast Regional Office 2870 Peachtree Road, PMB 196 Atlanta, Georgia 30305

Southeast Regional Office 2870 Peachtree Road, PMB 196 Atlanta, Georgia 30305 800-532-7667 856-488-4500 FAX: 856-661-9797 EMAIL: msaa@msassociation.org College of Pharmacy Oregon State University Attn: Oregon Pharmacy and Therapeutics Committee Corvallis, OR 97331 November 27th,

More information

Edasalonexent (CAT-1004) Program

Edasalonexent (CAT-1004) Program Edasalonexent (CAT-1004) Program Oral small molecule designed to inhibit NF-κB for the treatment of Duchenne muscular dystrophy Joanne M. Donovan, MD, PhD Chief Medical Officer, Catabasis Pharmaceuticals

More information

CHILDREN S HEALTH SURVEY

CHILDREN S HEALTH SURVEY CHILDREN S HEALTH SURVEY FOR ASTHMA CHILD VERSION The purpose of this survey is to find out how much asthma affects the everyday life of both you and your family. THERE ARE NO RIGHT OR WRONG ANSWERS!!

More information

Preventing Venous Thromboembolism (VTE)

Preventing Venous Thromboembolism (VTE) INTERNET INFORMATION SOURCES North American Thrombosis Forum www.natfonline.org Clot Care www.clotcare.com MANITOUWADGE GENERAL HOSPITAL National Alliance for Thrombosis/Thrombophilia www.stoptheclot.org

More information

Asthma Medications: Information for Children and Families. What You Need to Know about Medicines for Asthma

Asthma Medications: Information for Children and Families. What You Need to Know about Medicines for Asthma Page 1 of 8 PED-ALL-005-1992 Asthma Medications: Information for Children and Families What You Need to Know about Medicines for Asthma What Medicines Are used to Treat Asthma? There are two kinds of medicines:

More information

MER Baseline Enrollment Questionnaire. To be completed by Participant at time of Enrollment

MER Baseline Enrollment Questionnaire. To be completed by Participant at time of Enrollment MER Baseline Enrollment Questionnaire To be completed by Participant at time of Enrollment Mayo Clinic Return to: Lymphoma/CLL Study Coordinators Charlton 6 Internal Ext: 87039 1-800-610-7093 Instructions:

More information

Nephrotic Syndrome (Childhood Nephrosis)

Nephrotic Syndrome (Childhood Nephrosis) Nephrotic Syndrome (Childhood Nephrosis) This handout has been written to help you learn about nephrotic syndrome and how to take care of your child at home. If you have any questions, please be sure to

More information

Corticosteroid Treatment and Functional Improvement in Duchenne Muscular Dystrophy Long-Term Effect

Corticosteroid Treatment and Functional Improvement in Duchenne Muscular Dystrophy Long-Term Effect Authors: Birol Balaban, MD Dennis J. Matthews, MD Gerald H. Clayton, PhD Terri Carry, MS, PT Affiliations: From the Department of Physical Medicine and Rehabilitation, Gulhane Military Medical Academy,

More information

Cardiac Health in Duchenne: What we are Learning from Cardiac MRI

Cardiac Health in Duchenne: What we are Learning from Cardiac MRI Cardiac Health in Duchenne: What we are Learning from Cardiac MRI 24 th Annual Duchenne Connect Conference Parent Project Muscular Dystrophy Scottsdale, AZ June 29, 2018 Kan N. Hor, MD Director of Cardiac

More information

1/28/2019. OSF HealthCare INI Care Center Team. Neuromuscular Disease: Muscular Dystrophy. OSF HealthCare INI Care Center Team: Who are we?

1/28/2019. OSF HealthCare INI Care Center Team. Neuromuscular Disease: Muscular Dystrophy. OSF HealthCare INI Care Center Team: Who are we? Neuromuscular Disease: Muscular Dystrophy Muscular Dystrophy Association (MDA) and OSF HealthCare Illinois Neurological Institute (INI) Care Center Team The Neuromuscular clinic is a designated MDA Care

More information

Prolia 2 shots a year proven to help strengthen bones.

Prolia 2 shots a year proven to help strengthen bones. Ask your doctor if Prolia (denosumab) is right for you and visit us at www.prolia.com For women with postmenopausal osteoporosis at high risk for fracture: there s Prolia. Prolia 2 shots a year proven

More information

DOCTOR: The last time I saw you and your 6-year old son Julio was about 2 months ago?

DOCTOR: The last time I saw you and your 6-year old son Julio was about 2 months ago? DOCTOR: The last time I saw you and your 6-year old son Julio was about 2 months ago? MOTHER: Um, ya, I think that was our first time here. DOCTOR: Do you remember if you got an Asthma Action Plan? MOTHER:

More information

Growth and DMD Endocrine aspects of care

Growth and DMD Endocrine aspects of care Growth and DMD Endocrine aspects of care Meilan Rutter, MB,BCh, FRACP Division of Endocrinology Cincinnati Children s Hospital Medical Center July 2007 Where are we now? Inactive Reactive Proactive CCHMC

More information

CARE-NMD results. Jan Kirschner

CARE-NMD results. Jan Kirschner CARE-NMD results Jan Kirschner TREAT-NMD Alliance Meeting Newcastle 30 Oct -1 Nov 2013 Care recommendations for DMD Consensus process 2 Care recommendations for DMD Consensus process Scientific publication

More information

Edasalonexent (CAT-1004)

Edasalonexent (CAT-1004) Edasalonexent (CAT-1004) An NF-κB Inhibitor in Development for Patients with Duchenne Muscular Dystrophy Joanne M. Donovan, MD PhD Chief Medical Officer 17 February 2018 1 Forward Looking Statements This

More information

SeCondary Osteoporosis & its Therapy Duchenne Muscular Dystrophy SCOT-DMD

SeCondary Osteoporosis & its Therapy Duchenne Muscular Dystrophy SCOT-DMD SeCondary Osteoporosis & its Therapy Duchenne Muscular Dystrophy SCOT-DMD Acknowledgement S Joseph J Dunne M DiMarco C Duncanson I Horrocks S Shepherd and students Research radiographers & MRI Physics

More information

Season 1. No Smoking. Study Guide

Season 1. No Smoking. Study Guide Season 1 No Smoking Study Guide STUDY GUIDE CONTENTS No Smoking The Story Pages 1-10 Exercises Pages 11-25 Sasha loves to swim in the ocean in winter! He also likes to smoke. Helpful Information Pages

More information

Season 1. No Smoking. Study Guide

Season 1. No Smoking. Study Guide Season 1 No Smoking Study Guide STUDY GUIDE CONTENTS The Story Pages 1-10 Exercises Pages 11-25 Helpful Information Pages 26-28 Dictionary Pages 29-30 Dear Sasha Page 31 Answers Page 32 Watch Read Learn

More information

A TECH S TOOLKIT FOR THE PEDIATRIC SLEEP LAB

A TECH S TOOLKIT FOR THE PEDIATRIC SLEEP LAB A TECH S TOOLKIT FOR THE PEDIATRIC SLEEP LAB Craig Canapari, MD craig.canapari@gmail.com drcraigcanapari.com: Updated syllabus will be here along with link to visual presentation. Twitter: DrCanapari INTRODUCTION

More information

Femoral Neck (Hip) Fracture

Femoral Neck (Hip) Fracture Patient Information Leaflet Femoral Neck (Hip) Fracture Produced By: Orthopaedic Department September 2013 Review due September 2016 1 If you require this leaflet in another language, large print or another

More information

Welcome to Juvenile Rheumatoid Arthritis or JRA, by Connie Martin, MS, RDN; Claire Stephens, MS, RDN; and Lolita McLean, MPH, RDN...

Welcome to Juvenile Rheumatoid Arthritis or JRA, by Connie Martin, MS, RDN; Claire Stephens, MS, RDN; and Lolita McLean, MPH, RDN... Welcome to Juvenile Rheumatoid Arthritis or JRA, by Connie Martin, MS, RDN; Claire Stephens, MS, RDN; and Lolita McLean, MPH, RDN...all of Alabama s Children s Rehabilitation Service, part of the Alabama

More information

Osteoporosis after Spinal Cord Injury

Osteoporosis after Spinal Cord Injury Authors: SCIRE Community Team Reviewed by: Janice Eng, PhD, PT Last updated: Oct 11, 2017 Osteoporosis is a condition that can affect the bones after spinal cord injury (SCI). This page provides information

More information

-- Single Global Phase 3 Trial Expected to Begin in First Half of

-- Single Global Phase 3 Trial Expected to Begin in First Half of Catabasis Pharmaceuticals Reports Edasalonexent Preserved Muscle Function and Substantially Slowed Duchenne Muscular Dystrophy Disease Progression Through More Than One Year of Treatment -- Consistent

More information

CAREGIVER PERCEPTIONS AND ADOLESCENT QUALITY OF LIFE IN DUCHENNE MUSCULAR DYSTROPHY. Julia Rae Stone. BS, University of California, Davis, CA, 2014

CAREGIVER PERCEPTIONS AND ADOLESCENT QUALITY OF LIFE IN DUCHENNE MUSCULAR DYSTROPHY. Julia Rae Stone. BS, University of California, Davis, CA, 2014 CAREGIVER PERCEPTIONS AND ADOLESCENT QUALITY OF LIFE IN DUCHENNE MUSCULAR DYSTROPHY by Julia Rae Stone BS, University of California, Davis, CA, 2014 Submitted to the Graduate Faculty of the Department

More information

Early Onset Scoliosis

Early Onset Scoliosis Early Onset Scoliosis GSF-0616-326 Created in collaboration with: Growing Spine Foundation 555 East Wells Street, Suite 1100 Milwaukee, WI 53202 USA P: (414) 276-6445 F: (414) 276-3349 info@growingspine.org

More information

Fitness for Life. Unit 3

Fitness for Life. Unit 3 Fitness for Life Unit 3 Chapter 10 Range of Motion vs. Stretching Range of Motion: The amount of movement you can make at a joint Hypermobility: The ability to extend a joint beyond a straight line Stretching:

More information

The 2017 Update of the Standard of Care Recommendations for Spinal Muscular Atrophy

The 2017 Update of the Standard of Care Recommendations for Spinal Muscular Atrophy Richard Finkel, MD Nemours Children s Hospital Orlando, FL, USA Thomas Crawford, MD Johns Hopkins Hospital Baltimore, MD, USA The 2017 Update of the Standard of Care Recommendations for Spinal Muscular

More information

Introduction Posterior cervical fusion is done through the back posterior of the neck. The surgery joins two or more neck vertebrae into one solid section of bone. The medical term for fusion is arthrodesis.

More information

CHILDHOOD C 3 HANGE CARE TOOL: PROVIDER REPORT

CHILDHOOD C 3 HANGE CARE TOOL: PROVIDER REPORT Date: / / Patient s Project ID# For use as-needed in clinic visits A SURVEY TO LEARN ABOUT A PATIENT S NEEDS AND ABILITIES: Health care providers of children and adolescents aged 5 to 2 How is this patient

More information

Clinical Policy: Eteplirsen Reference Number: NH.PHAR.288 Effective Date: 12/16

Clinical Policy: Eteplirsen Reference Number: NH.PHAR.288 Effective Date: 12/16 Clinical Policy: Reference Number: NH.PHAR.288 Effective Date: 12/16 Last Review Date: 12/17 Revision Log See Important Reminder at the end of this policy for important regulatory and legal information.

More information

-- Edasalonexent Substantially Slowed Duchenne Muscular Dystrophy Disease Progression through 36 Weeks --

-- Edasalonexent Substantially Slowed Duchenne Muscular Dystrophy Disease Progression through 36 Weeks -- Catabasis Pharmaceuticals Reports Positive Results from Open-Label Extension of Phase 2 MoveDMD Trial Evaluating Edasalonexent in Duchenne Muscular Dystrophy and Plans to Initiate Phase 3 Clinical Trial

More information

Osteoporosis in Duchenne Muscular Dystrophy. Prasanth Surampudi, MD Associate Professor Division of Endocrinology UC Davis Medical Center, Davis, CA

Osteoporosis in Duchenne Muscular Dystrophy. Prasanth Surampudi, MD Associate Professor Division of Endocrinology UC Davis Medical Center, Davis, CA Osteoporosis in Duchenne Muscular Dystrophy Prasanth Surampudi, MD Associate Professor Division of Endocrinology UC Davis Medical Center, Davis, CA OUTLINE Background: Bone Basics & Osteoporosis Bone Changes

More information

Catabasis Pharmaceuticals Q May 2018

Catabasis Pharmaceuticals Q May 2018 Catabasis Pharmaceuticals Q1 2018 May 2018 Forward Looking Statements This presentation contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995, including

More information

PPMD Annual Meeting, June 29 th 2018 Dr. Paolo Bettica, VP R&D

PPMD Annual Meeting, June 29 th 2018 Dr. Paolo Bettica, VP R&D PPMD Annual Meeting, June 29 th 2018 Dr. Paolo Bettica, VP R&D Disclosure and Disclaimer Dr. Bettica is a full time employee of Italfarmaco, the manufacturer of Givinostat Givinostat (ITF2357) is currently

More information

Before you start go to page 2. Leeds West Clinical Commissioning Group

Before you start go to page 2. Leeds West Clinical Commissioning Group Leeds West Clinical Commissioning Group If you or one of your friends has asthma we want you to tell us how you feel. We also want your parents or carers to tell us how they help you look after yourself.

More information

Living with COPD: 5 steps to better lung health

Living with COPD: 5 steps to better lung health Living with COPD: 5 steps to better lung health Breathe better Feel good Do more Name: Date: COPD or chronic obstructive pulmonary disease mainly affects your lungs and how well you can breathe, but it

More information

Height: Weight: Neck Size: Does your work involve shift work? Yes No. Where did you hear about us: Physician Media Friend Other

Height: Weight: Neck Size: Does your work involve shift work? Yes No. Where did you hear about us: Physician Media Friend Other Personal Information Name: Date of birth: Sex: Male Female Marital Status: Nationality: MRN(for KAUH Patients): Height: Weight: Neck Size: Address: Occupation: Length of work day: Does your work involve

More information

Osteoporosis and Lupus. Andrew Ruthberg, MD University Rheumatologists

Osteoporosis and Lupus. Andrew Ruthberg, MD University Rheumatologists Osteoporosis and Lupus Andrew Ruthberg, MD University Rheumatologists 1 Forget the medical terminology (osteoporosis, osteopenia, low bone mass, DEXA, DXA, T score etc) The bottom line is that you don

More information

Online Data Supplement Primary Ciliary Dyskinesia: First Health-related Quality of Life Measures for Pediatric Patients

Online Data Supplement Primary Ciliary Dyskinesia: First Health-related Quality of Life Measures for Pediatric Patients Online Data Supplement Primary Ciliary Dyskinesia: First Health-related Quality of Life Measures for Pediatric Patients Sharon D Dell, Margaret W. Leigh, Jane S Lucas, Thomas W. Ferkol, Michael R. Knowles,

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: (Exondys 51) Reference Number: CP.PHAR.288 Effective Date: 12.01.16 Last Review Date: 02.18 Line of Business: Commercial, Health Insurance Marketplace, Medicaid Revision Log See Important

More information

Skeletal Manifestations

Skeletal Manifestations Skeletal Manifestations of Metabolic Bone Disease Mishaela R. Rubin, MD February 21, 2008 The Three Ages of Women Gustav Klimt 1905 1 Lecture Outline Osteoporosis epidemiology diagnosis secondary causes

More information

Name: _Stacy Hall. Grade Level: _7th. Unit / Content Area:_Personal Health and Physical Activity. Lesson Title: _A Healthy Body, A Healthy Weight

Name: _Stacy Hall. Grade Level: _7th. Unit / Content Area:_Personal Health and Physical Activity. Lesson Title: _A Healthy Body, A Healthy Weight Lesson Plan Format Name: _Stacy Hall Grade Level: _7th Unit / Content Area:_Personal Health and Physical Activity Lesson Title: _A Healthy Body, A Healthy Weight Objectives Objective 1: _During lesson

More information

Osteoporosis challenges

Osteoporosis challenges Osteoporosis challenges Osteoporosis challenges Who should have a fracture risk assessment? Who to treat? Drugs, holidays and unusual adverse effects Fracture liaison service? The size of the problem 1

More information

COPD. Helen Suen & Lexi Smith

COPD. Helen Suen & Lexi Smith COPD Helen Suen & Lexi Smith What is COPD? Chronic obstructive pulmonary disease: a non reversible, long term lung disease Characterized by progressively limited airflow and an inability to perform full

More information

All about Osteoporosis symptoms, diagnosis, treatment

All about Osteoporosis symptoms, diagnosis, treatment Health & Fitness Published : 07 Sep 2017, 14:41 All about Osteoporosis symptoms, diagnosis, treatment By : BD Post Desk Osteoporosis is a bone disease. Its name comes from the Latin for porous bones. The

More information

keep track of other information like warning discuss with your doctor, and numbers of signs for relapse, things you want to

keep track of other information like warning discuss with your doctor, and numbers of signs for relapse, things you want to Helping you set your brain free from psychosis. www.heretohelp.bc.ca This book was written by Sophia Kelly and the BC Schizophrenia Society, for the BC Partners for Mental Health and Addictions Information.

More information

FREQUENTLY ASKED QUESTIONS

FREQUENTLY ASKED QUESTIONS FREQUENTLY ASKED QUESTIONS The following questions are representative of questions that patients and family members ask when they visit the Bone and Cancer Foundation website or contact the Foundation

More information

Closing the Care Gap in Osteoporosis ICE Conference 2015

Closing the Care Gap in Osteoporosis ICE Conference 2015 Closing the Care Gap in Osteoporosis ICE Conference 2015 Pat McCarthy-Briggs RD, MHEd Thank You! What is osteoporosis? a systemic skeletal disease characterized by low bone mass and microarchitectural

More information

AUDIT OF BONE HEALTH IN DUCHENNE MUSCULAR DYSTROPHY

AUDIT OF BONE HEALTH IN DUCHENNE MUSCULAR DYSTROPHY AUDIT OF BONE HEALTH IN DUCHENNE MUSCULAR DYSTROPHY Audit report completed February 2016 GAIN Bone Health in Duchenne Muscular Dystrophy 2014_PART 1 Summary Page 1 of 27 Contents page number Executive

More information

Quality of Life in Epilepsy for Adolescents: QOLIE-AD-48 (Version 1)

Quality of Life in Epilepsy for Adolescents: QOLIE-AD-48 (Version 1) Quality of Life in Epilepsy for Adolescents: QOLIE-AD-48 (Version 1) QOLIE-AD-48 1999, QOLIE Development Group. All rights reserved. Today's Date / / Name: INSTRUCTIONS The QOLIE-AD-48 is a survey of health-related

More information

UNIVERSITY OF ARKANSAS RESPIRATORY PROTECTION PROGRAM REQUEST FOR USE & MEDICAL EVALUATION QUESTIONNAIRE

UNIVERSITY OF ARKANSAS RESPIRATORY PROTECTION PROGRAM REQUEST FOR USE & MEDICAL EVALUATION QUESTIONNAIRE UNIVERSITY OF ARKANSAS RESPIRATORY PROTECTION PROGRAM REQUEST FOR USE & MEDICAL EVALUATION QUESTIONNAIRE PART 1. SECTION A. Mandatory. Every employee who has been selected to use any type of respirator

More information

A Patient s Guide to Cervical Foraminotomy

A Patient s Guide to Cervical Foraminotomy A Patient s Guide to Cervical Foraminotomy 15195 Heathcote Blvd Suite 334 Haymarket, VA 20169 Phone: 703-369-9070 Fax: 703-369-9240 DISCLAIMER: The information in this booklet is compiled from a variety

More information

Anxiety- Information and a self-help guide

Anxiety- Information and a self-help guide Anxiety- Information and a self-help guide Anxiety Anxiety can be a very normal and healthy response to stressful situations, such as paying bills or sitting an exam. However, it becomes a problem when

More information

The Osteoporosis Center at St. Luke s Hospital

The Osteoporosis Center at St. Luke s Hospital The Osteoporosis Center at St. Luke s Hospital Desloge Outpatient Center (on the west side of 141) 121 St. Luke s Center Drive, Suite 504 Chesterfield, MO 63017 Phone 314 205-6633 Fax 314 590-5909 NEW

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: (Exondys 51) Reference Number: CP.CPA.188 Effective Date: 02.15.16 Last Review Date: 11.17 Line of Business: Medicaid Medi-Cal Revision Log See Important Reminder at the end of this policy

More information

Gene Therapy With a Difference By ANDREW POLLACK

Gene Therapy With a Difference By ANDREW POLLACK September 23, 2013 Gene Therapy With a Difference By ANDREW POLLACK Terri Ellsworth is convinced that her 12-year-old son Billy, who has Duchenne muscular dystrophy, is being helped by an experimental

More information

Prolia 2 shots a year proven to help strengthen bones. next shot appointment

Prolia 2 shots a year proven to help strengthen bones. next shot appointment Ask your doctor if Prolia (denosumab) is right for you and visit us at www.prolia.com next shot appointment For women with postmenopausal osteoporosis at high risk for fracture: there s Prolia. Prolia

More information

Osteoporosis. Skeletal System

Osteoporosis. Skeletal System Osteoporosis Introduction Osteoporosis is a very common bone disease that causes bone to become weak. Bone weakness can lead to fractures of the spine, hip, and wrist from simple falls or even a sneeze

More information

Sample blf.org.uk/copd

Sample blf.org.uk/copd Your COPD self-management plan blf.org.uk/copd Thank you to the people with lung conditions and leading health care professionals who helped to develop this plan. This resource has been developed in partnership

More information

I bet you never thought that grapefruit juice could kill you. Did you? No you didn t. Don t lie.

I bet you never thought that grapefruit juice could kill you. Did you? No you didn t. Don t lie. I bet you never thought that grapefruit juice could kill you. Did you? No you didn t. Don t lie. It s so delicious! Look at this girl she clearly LOVES IT. How can something sooooo good be soooooo bad?

More information

Raxone (idebenone) and pulmonary care in Duchenne Muscular Dystrophy (DMD)

Raxone (idebenone) and pulmonary care in Duchenne Muscular Dystrophy (DMD) Raxone (idebenone) and pulmonary care in Duchenne Muscular Dystrophy (DMD) Thomas Meier, PhD February 2018 Agenda Medical need for effective treatment of respiratory illness in DMD Understanding respiratory

More information

What You Can Do About a Lung Disease Called COPD

What You Can Do About a Lung Disease Called COPD GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE What You Can Do About a Lung Disease Called COPD Adults may have COPD if they have trouble breathing or a cough that will not go away. BASED ON THE

More information

What You Need to Know About Lung Cancer Immunotherapy

What You Need to Know About Lung Cancer Immunotherapy What You Need to Know About Lung Cancer Immunotherapy Lung.org/immunotherapy What is immunotherapy? Immunotherapy for cancer, sometimes called immune-oncology, is a type of medicine that treats cancer

More information

Catch the HEDIS Buzz!

Catch the HEDIS Buzz! Catch the HEDIS Buzz! Focus Area: Osteoporosis Management in Women Who Had a Fracture Date: October 2014 HEDIS Performance Score In 2013, Humana At Home associates did a great job of promoting Osteoporosis

More information

Medical History. Participant Id#: Acrostic: Tech ID#: Date: / / 1 How would you say your health currently compares with other persons of your age?

Medical History. Participant Id#: Acrostic: Tech ID#: Date: / / 1 How would you say your health currently compares with other persons of your age? Multi-Ethnic Study of Atherosclerosis Exam 5 Participant Id#: Acrostic: Tech ID#: Medical History Interviewer Administered Date: / / Month Day Year The following are some questions about your medical history.

More information

N N X X === === === === N N X X === u u s s. Physician Signature: OrthoNeuro

N N X X === === === === N N X X === u u s s. Physician Signature: OrthoNeuro Physician Signature: OrthoNeuro Date: Name: Date: Age: SS#: Sex: DOB: Referring Physician: Referring Physician Address: Mark the areas on the corresponding figures where you feel the described sensations.

More information

Accessing EMFLAZA (deflazacort) for Duchenne muscular Dystrophy PPMD 2017 Connect Conference June 29, 2017; 4:00pm Stuart Peltz, PhD PTC

Accessing EMFLAZA (deflazacort) for Duchenne muscular Dystrophy PPMD 2017 Connect Conference June 29, 2017; 4:00pm Stuart Peltz, PhD PTC Accessing EMFLAZA (deflazacort) for Duchenne muscular Dystrophy PPMD 2017 Connect Conference June 29, 2017; 4:00pm Stuart Peltz, PhD PTC Therapeutics, South Plainfield, NJ Forward looking statements within

More information

Using the FRAX Tool. Osteoporosis Definition

Using the FRAX Tool. Osteoporosis Definition How long will your bones remain standing? Using the FRAX Tool Gary Salzman M.D. Director Banner Good Samaritan/ Hayden VAMC Internal Medicine Geriatric Fellowship Program Phoenix, Arizona Using the FRAX

More information

CAPL 2 Questionnaire

CAPL 2 Questionnaire CAPL 2 Questionnaire What Do You Think About Physical Activity? When we ask you about physical activity, we mean when you are moving around, playing, or exercising. Physical activity is any activity that

More information

For the Patient: USMAVNIV

For the Patient: USMAVNIV For the Patient: USMAVNIV Other Names: Treatment of Unresectable or Metastatic Melanoma Using Nivolumab U = Undesignated (requires special approval) SM = Skin and Melanoma AV = AdVanced NIV = NIVolumab

More information

Pediatric Patients. Neuromuscular Disease. Teera Kijmassuwan, MD Phetcharat Netmuy, B.N.S., MA Oranee Sanmaneechai, MD : Preceptor

Pediatric Patients. Neuromuscular Disease. Teera Kijmassuwan, MD Phetcharat Netmuy, B.N.S., MA Oranee Sanmaneechai, MD : Preceptor Patient Management Pediatric Patients with Neuromuscular Disease Teera Kijmassuwan, MD Phetcharat Netmuy, B.N.S., MA Oranee Sanmaneechai, MD : Preceptor Case Thai boy 1 year old Present with Respiratory

More information

Adolescent Sleep Disorder Questionnaire For Children Ages PATIENT NAME: (Please print clearly) Patient s Date of Birth: Age: Male Female

Adolescent Sleep Disorder Questionnaire For Children Ages PATIENT NAME: (Please print clearly) Patient s Date of Birth: Age: Male Female (PATIENT) Adolescent Sleep Disorder Questionnaire For Children Ages 12-17 Instructions: Please review this form for accuracy prior to submission. You may complete this information prior to arrival at the

More information

Duchenne muscular dystrophy Report from questionnaires

Duchenne muscular dystrophy Report from questionnaires 7--8 Orofacial function of persons having Duchenne muscular dystrophy Report from questionnaires The survey comprises questionnaires. Estimated occurrence: : inhabitants. Only affects boys Etiology: A

More information

Screening tests. When you need them and when you don t

Screening tests. When you need them and when you don t Screening tests When you need them and when you don t S creening tests help doctors look for diseases when you don t have symptoms. The tests can Screenings find problems early, when they are easier to

More information

fighting for young people s mental health #FightingFor Report

fighting for young people s mental health #FightingFor Report 25 5 fighting for young people s mental health #FightingFor Report youngminds.org.uk Introduction YoungMinds was formed in 1993 by a group of children s mental health professionals who were passionate

More information